메뉴 건너뛰기




Volumn 256, Issue 4, 2009, Pages 554-562

Multiple sclerosis patients′ benefit-risk preferences: Serious adverse event risks versus treatment efficacy

Author keywords

Benefit risk analysis; Conjoint analysis; Maximum acceptable risk; Multiple sclerosis; Side effect risk

Indexed keywords

NATALIZUMAB;

EID: 65749119370     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-009-0084-2     Document Type: Article
Times cited : (114)

References (38)
  • 1
    • 65749111685 scopus 로고    scopus 로고
    • Lessons from the New Jersey Comparative Risk Project
    • Linkov I, Ramadan AB (eds) Netherlands: Springer
    • Andrews CJ (2005) Lessons from the New Jersey Comparative Risk Project. In: Linkov I, Ramadan AB (eds) Comparative Risk Assessment and Environmental Decision Making. Netherlands: Springer
    • (2005) Comparative Risk Assessment and Environmental Decision Making
    • Andrews, C.J.1
  • 2
  • 13
    • 0027207561 scopus 로고
    • Gregory 1993 Analysis 13 259
    • (1993) Analysis , vol.13 , pp. 259
    • Gregory1
  • 14
    • 65749095763 scopus 로고    scopus 로고
    • Health Talk Available at: Last accessed 4/26/2006
    • Health Talk (2006) Available at: www.healthtalk.com. Last accessed 4/26/2006
    • (2006) Www.healthtalk.com.
  • 16
    • 0026133945 scopus 로고
    • Hughes 1991 Med Care 29 297
    • (1991) Med Care , vol.29 , pp. 297
    • Hughes1
  • 18
    • 33750338501 scopus 로고    scopus 로고
    • Institute of Medicine Committee on the Assessment of the US Drug Safety System Alina Baciu, Kathleen Stratton, Sheila P. Burke (eds) National Academy of Sciences: Washington, D.C.
    • Institute of Medicine Committee on the Assessment of the US Drug Safety System(2006) The Future of Drug Safety: Promoting and Protecting the Health of the Public. In: Alina Baciu, Kathleen Stratton, Sheila P. Burke (eds) National Academy of Sciences: Washington, D.C.
    • (2006) The Future of Drug Safety: Promoting and Protecting the Health of the Public
  • 21
    • 34249023909 scopus 로고    scopus 로고
    • Johnson 2007 Med Care 45 545
    • (2007) Med Care , vol.45 , pp. 545
    • Johnson1
  • 25
    • 33745675511 scopus 로고    scopus 로고
    • Kobelt 2006 Neurology 66 1696
    • (2006) Neurology , vol.66 , pp. 1696
    • Kobelt1
  • 29
    • 4644338395 scopus 로고
    • Decision Analysis and FDA Drug Review: A Proposal for Shadow Advisory Committees
    • Mendeloff J (1995) Decision Analysis and FDA Drug Review: A Proposal for Shadow Advisory Committees. Risk (Summer):203-214
    • (1995) Risk , Issue.SUMMER , pp. 203-214
    • Mendeloff, J.1
  • 34
    • 0023324565 scopus 로고
    • Slovic 1987 Science 236 280
    • (1987) Science , vol.236 , pp. 280
    • Slovic1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.